Galena Biopharma, Inc. SLS 深 滬
等待開盤 12-25 09:30:00 美东时间
2.84
+0.070
+2.53%
華盛通- 最 高3.00
- 今 開2.78
- 成交量 619.76万股
- 最 低 2.73
- 昨 收 2.77
- 總市值 4.03亿
- 52周最高 3.00
- 市盈率 靜 --
- 換手率 4.36%
- 52周最低 0.8505
- 委 比 76.12%
- 總股本 1.42亿
- 歷史最高 554.50
- 量 比 0.77
- 振 幅 9.75%
- 歷史最低 0.4986
- 每 手 1
- 風險率 0.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 0.1% on Tuesday...
12-23 23:15
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
SELLAS announced promising Phase 2 study results for SLS009 combined with AZA/VEN in treating relapsed/refractory AML-MR. The treatment achieved a 46% overall response rate (48% for ASXL1, 57% for TP53 mutations) and significant survival benefits (mOS 8.9 months in the least pretreated cohort). The combination was well-tolerated with no dose-limiting toxicities. The company plans to expand the study to newly diagnosed high-risk AML patients in Q1...
12-07 23:00
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary VANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia ...
12-05 01:20
SELLAS Life Sciences Gr Q3 EPS $(0.06) Beats $(0.09) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 29.41 percent. This is a 40 percent increase over losses of $(0.10) per share
11-13 05:52
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
SELLAS Life Sciences Group reported positive developments in its AML-focused pipeline, including Phase 2 data for SLS009 accepted at the ASH Annual Meeting and plans for a Phase 3 trial in newly diagnosed AML patients. The company also highlighted progress in the Phase 3 REGAL trial for GPS and successful preclinical data for SLS009 in T-PLL. Additionally, the company received $54.6 million from warrant exercises, boosting its cash position to $4...
11-12 21:05
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
11-12 01:35
SELLAS Life Sciences To Present Data From Ongoing Phase 2 Study Of SLS009 For Treatment Of r/r AML At ASH 2025
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today
11-03 22:12
敏感肌可以用，5 款温和有效控油蓬松洗发水推荐，临床验证持久80小时
夏天在工地搬砖 2 小时，头发油得能粘住安全帽；秋冬开暖气，头油混着静电，碎发全贴在脸颊上；宝妈带娃忙到半夜，早上连洗头时间都没有，头发油得只能扎紧马尾遮 “秃...
10-29 12:20
电商资讯：TikTok在脉脉发布多个百万年薪岗位...
国内资讯 【国内电商】天猫双11：火锅底料食材销量同比增长超过100% 10月25日消息，天猫双11遇上全国降温，火锅周边销量大涨。淘宝天猫数据显示，火锅底...
10-28 17:03
国金机械丨机械行业周报：看好工程机械、量子计算、核聚变、机器人和农机
（来源：满仓机械） + 目录 摘要 行情回顾： 本周板块表现：上周（2025/10/20-2025/10/24）5个交易日，SW机械...
10-26 21:47
